Spectrum-Vascular-Logo-1750x583

References

  1. Kagan E, Salgado CD, Banks AL, Marculescu CE, Cantey JR. Peripherally inserted central catheter-associated bloodstream infection: Risk factors and the role of antibiotic-impregnated catheters for prevention. Am J Infect Control. 2019;47(2):191-195.doi:10.1016/j.ajic.2018.07.006
  2. Kramer RD, Rogers MA, Conte M, Mann J, Saint S, Chopra V. Are antimicrobial peripherally inserted central catheters associated with reduction in central line-associated bloodstream infection? A systematic review and meta-analysis. Am J Infect Control. 2017;45(2):108-114. doi:10.1016/j.ajic.2016.07.021
  3. Bonne S, Mazuski JE, Sona C, et al. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial. J Am Coll Surg. 2015;221(3):739-747. doi:10.1016/j.jamcollsurg.2015.05.013
  1. Baskin KM, Hunnicutt C, Beck ME, Cohen ED, Crowley JJ, Fitz CR. Long-term central venous access in pediatric patients at high risk: conventional versus antibiotic-impregnated catheters. J Vasc Interv Radiol. 2014;25(3):411-418. doi:10.1016/j.jvir.2013.11.024
  1. Chaftari AM, Kassis C, El Issa H, et al. Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients. Cancer. 2011;117(11):2551-2558. doi:10.1002/cncr.25807
  1. Hockenhull JC, Dwan KM, Smith GW, et al. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review. Crit Care Med. 2009;37(2):702-712. doi:10.1097/CCM.0b013e3181958915
  1. Ramritu P, Halton K, Collignon P, et al. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control. 2008;36(2):104-117. doi:10.1016/j.ajic.2007.02.012
  1. Casey AL, Mermel LA, Nightingale P, Elliott TS. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8(12):763-776. doi:10.1016/S1473-3099(08)70280-9
  1. Gilbert RE, Harden M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Curr Opin Infect Dis. 2008;21(3):235-245. doi:10.1097/QCO.0b013e3282ffd6e0
  1. Schuerer DJ, Zack JE, Thomas J, et al. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial. Surg Infect (Larchmt). 2007;8(4):445-454. doi:10.1089/sur.2006.073
  1. Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2007;59(3):359-369. doi:10.1093/jac/dkl522
  1. Hanna H, Bahna P, Reitzel R, et al. Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother. 2006;50(10):3283-3288. doi:10.1128/AAC.01622-05
  1. Still J, Law E, Friedman B, Fuhrman S, Newton T. Vancomycin-resistant organisms on a burn unit. South Med J. 2001;94(8):810-812.
  1. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med. 1999;340(1):1-8. doi:10.1056/NEJM199901073400101
  1. Wenzel RP, Edmond MB. The evolving technology of venous access. N Engl J Med. 1999;340(1):48-50. doi:10.1056/NEJM199901073400109
  1. Marik PE, Abraham G, Careau P, Varon J, Fromm RE Jr. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med. 1999;27(6):1128-1131. doi:10.1097/00003246-199906000-00034
  1. Raad II, Darouiche RO, Hachem R, et al. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampin. Crit Care Med. 1998;26(2):219-224. doi:10.1097/00003246-199802000-00015
  1. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med. 1997;127(4):267-274. doi:10.7326/0003-4819-127-4-199708150-00002
  1. Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria. J Antimicrob Chemother. 2008;62(4):746-750. doi:10.1093/jac/dkn281
  1. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis. 1996;173(2):418-424. doi:10.1093/infdis/173.2.418
  1. Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother. 1995;39(11):2397-2400. doi:10.1128/AAC.39.11.2397
  1. Darouiche RO, Raad II, Bodey GP, Musher DM. Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter-related bacteremia: potential role of the combination of minocycline and rifampin. Int J Antimicrob Agents. 1995;6(1):31-36. doi:10.1016/0924-8579(95)00017-3
  1. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med. 2006;34(8):2084-2089. doi:10.1097/01.CCM.0000227648.15804.2D
  1. Cosgrove SE. Evidence that prevention makes cents: Costs of catheter-associated bloodstream infections in the intensive care unit. Crit Care Med. 2006;34(8):2243-2244. doi:10.1097/01.CCM.0000229637.32517.90
  1. Hanna HA, Raad II, Hackett B, et al. Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients. Chest. 2003;124(3):1030-1038. doi:10.1378/chest.124.3.1030
  1. Shorr AF, Humphreys CW, Helman DL. New choices for central venous catheters: potential financial implications. Chest. 2003;124(1):275-284.
  1. Marciante KD, Veenstra DL, Lipsky BA, Saint S. Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use. Am J Infect Control. 2003;31(1):1-8. doi:10.1067/mic.2003.35
  1. Shojania KG, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ. Making health care safer: a critical analysis of patient safety practices. Evid Rep Technol Assess (Summ). 2001;(43):i-668.
  1. Turnbull IR, Buckman SA, Horn CB, Bochicchio GV, Mazuski JE. Antibiotic-Impregnated Central Venous Catheters Do Not Change Antibiotic Resistance Patterns. Surg Infect (Larchmt). 2018;19(1):40-47. doi:10.1089/sur.2017.087
  1. Ramos ER, Reitzel R, Jiang Y, et al. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med. 2011;39(2):245-251. doi:10.1097/CCM.0b013e3181feb83e
  1. Chatzinikolaou I, Hanna H, Graviss L, et al. Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance. Infect Control Hosp Epidemiol. 2003;24(12):961-963. doi:10.1086/502167
  1. Crnich CJ, Maki DG. New technology for reducing infection and resistance in the ICU. J Crit Illn. 2002;17;48-51. highbeam.com/4312/article-1G1-83373440/new-technology-reducing-infection-and-resistance-icu
  1. Brooks K, Dauenhauer S, Nelson M. Comparison of an untreated vs. silver/chlorhexidine vs. rifampin/minocycline central venous catheter in reducing catheter-related bloodstream infections. Abstract presented at: APIC 28th Annual Educational Conference and International Meeting; June 10-14, 2001; Seattle, WA.
  1. Friedman BC, Mian MA, Mullins RF, Hassan Z, Shaver JR, Johnston KK. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates. J Burn Care Res. 2015;36(4):493-499. doi:10.1097/BCR.0000000000000186
  1. Armstrong SD, Thomas W, Neaman KC, Ford RD, Paulson J. The impact of antibiotic impregnated PICC lines on the incidence of bacteremia in a regional burn center. Burns. 2013;39(4):632-635. doi:10.1016/j.burns.2012.08.017
  1. Weber JM, Sheridan RL, Fagan S, Ryan CM, Pasternack MS, Tompkins RG. Incidence of catheter-associated bloodstream infection after introduction of minocycline and rifampin antimicrobial-coated catheters in a pediatric burn population. J Burn Care Res. 2012;33(4):539-543. doi:10.1097/BCR.0b013e31823c4cd5
  1. Darouiche RO, Berger DH, Khardori N, et al. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg. 2005;242(2):193-200. doi:10.1097/01.sla.0000171874.29934.61
  1. Hanna H, Benjamin R, Chatzinikolaou I, et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol. 2004;22(15):3163-3171. doi:10.1200/JCO.2004.04.124